[1]苏胤杰 张朝军.代谢手术对胰腺β细胞功能的影响[J].中华肥胖与代谢病电子杂志,2016,2(02):111-113.[doi:10.3877//cma.j.issn.2095-9605.2016.02.011]
点击复制

代谢手术对胰腺β细胞功能的影响()
分享到:

《中华肥胖与代谢病电子杂志》[ISSN:2095-9605/CN:11-9362]

卷:
第2卷
期数:
2016年02期
页码:
111-113
栏目:
综述
出版日期:
2016-06-29

文章信息/Info

作者:
苏胤杰1 张朝军2
400038 重庆,第三军医大学学员旅学员八营1; 100048北京,中国人民解放军海军总医院普通外科2
关键词:
减肥手术 糖尿病2型 胰腺β细胞
DOI:
10.3877//cma.j.issn.2095-9605.2016.02.011

参考文献/References:

[1] Ley SH, Hamdy O, Mohan V, et al. Prevention and managementof type 2 diabetes: dietary components and nutritional stategies[J].Lancet, 2014, 383(9933):1999-2007.
[2] Pories WJ, Caro JF, Flickinger EG, et al. The control of diabetesmellitus (NIDDM) in the morbidly obese with the Greenville GastricBypass[J]. Ann Surg, 1987, 206(3):316-323.
[3] Goldfine AB, Patti ME. Diabetes: Bariatric surgery for T2DM-cure,or remission and relapse?[J]. Nat Rev Endocrinol, 2014, 10(1):8-9.
[4] Reinke T. Bariatric surgery called cure for some diabetes patients[J].Manag Care, 2014, 23(1):39-42.
[5] Varela JE. Bariatric surgery: a cure for diabetes?[J]. Curr Opin ClinNutr Metab Care, 2011, 14(4):396-401.
[6] Smith BR, Hinojosa MW, Reavis KM, et al. Remission of diabetesafter laparoscopic gastric bypass[J]. Am Surg, 2008, 74(10):948-952.
[7] Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetesafter bariatric surgery: systematic review and meta-analysis[J]. Am JMed, 2009, 122(3):248-256.
[8] Holst JJ. Enteroendocrine secretion of gut hormones in diabetes, obesity andafter bariatric surgery[J]. Curr Opin Pharmacol, 2013, 13(6):983-988.
[9] Rao RS. Bariatric surgery and the central nervous system[J]. ObesSurg, 2012, 22(6):967-978.
[10] Meier JJ, Butler AE, Galasso R, et al. Hyperinsulinemic hypoglycemiaafter gastric bypass surgery is not accompanied by islet hyperplasia orincreased beta-cell turnover[J]. Diabetes Care, 2006, 29:1554-1559.
[11] Martínez-Moreno JM, Garciacaballero M. Influences of the diabetes surgeryon pancreatic β-cells mass[J]. Nutr Hosp, 2013, 28(Suppl 2):88-94.
[12] Su Y, Zhao Y, Zhang C. Bariatric surgery: beta cells in type 2 diabetesremission[J]. Diabetes Metab Res Rev, 2016, 32(2):122-131.
[13] Rhodes CJ. Type 2 diabetes-a matter of beta-cell life and death?[J].Science, 2005, 307(5708):380-384.
[14] Reubi JC, Perren A, Rehmann R, et al. Glucagon-like peptide-1(GLP-1) receptors are not overexpressed in pancreatic islets frompatients with severe hyperinsulinaemic hypoglycaemia followinggastric bypass[J]. Diabetologia, 2010, 53(12):2641-2645.
[15] Jacobsen SH, Olesen SC, Dirksen C, et al. Changes in gastrointestinalhormone responses, insulin sensitivity, and beta-cell function within2 weeks after gastric bypass in non-diabetic subjects[J]. Obes Surg,2012, 22(7):1084-1096.
[16] Rabiee A, Magruder JT, Salas-Carrillo R, et al. Hyperinsulinemichypoglycemia after Roux-en-Y gastric bypass: unraveling the role ofgut hormonal and pancreatic endocrine dysfunction[J]. J Surg Res,2011, 167(2):199-205.
[17] de Luis D, Domingo M, Romero A, et al. Effects of duodenal-jejunalexclusion on beta cell function and hormonal regulation in Goto-Kakizaki rats[J]. Am J Surg, 2012, 204(2):242-247.
[18] Cai L, Li W, Wang G, et al. Hyperglycemia-induced apoptosis inmouse myocardium: mitochondrial cytochrome C-mediated caspase-3activation pathway[J]. Diabetes, 2002, 51(6):1938-1948.
[19] Wold LE, Ceylan-Isik AF, Fang CX, et al. Metallothionein alleviates cardiacdysfunction in streptozotocin-induced diabetes: role of Ca2+ cycling proteins,NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chainisozyme[J]. Free Radic Biol Med, 2006, 40(8):1419-1429.
[20] Li J, Wang P, Yu S, et al. Calcium entry mediates hyperglycemia-induced apoptosis through Ca(2+)/calmodulin-dependent kinase II inretinal capillary endothelial cells[J]. Mol Vis, 2012(18):2371-2379.
[21] Müller I, Lipp P, Thiel G. Ca2+ signaling and gene transcription in glucose-stimulated insulinoma cells[J]. Cell Calcium, 2012, 52(2):137-151.
[22] Giorgi C, Baldassari F, Bononi A, et al. Mitochondrial Ca(2+) andapoptosis[J]. Cell Calcium, 2012, 52(1):36-43.
[23] Herchuelz A, Nguidjoe E, Jiang L, et al.β-Cell preservation andregeneration in diabetes by modulation of β-cell Ca2+ homeostasis[J].Diabetes Obes Metab, 2012, 14(Suppl 3):136-142.
[24] Chai F, Wang Y, Zhou Y, et al. Adiponectin downregulateshyperglycemia and reduces pancreatic islet apoptosis after roux-en-ygastric bypass surgery[J]. Obes Surg, 2011, 21(6):768-773.
[25] Huypens PR. Leptin and adiponectin regulate compensatory betacell growth in accordance to overweight[J]. Med Hypotheses, 2007,68(5):1134-1137.
[26] 田晓丰 , 曹宏 , 陈丹磊 , 等 . 胃旁路术对糖尿病大鼠胰岛 β 细胞凋亡的影响及其机制研究 [J]. 中华外科杂志 , 2010, 48(23):1794-1799.
[27] Yang J, Feng X, Zhong S, et al. Gastric bypass surgery may improvebeta cell apoptosis with ghrelin overexpression in patients withBMI ≥ 32.5 kg/m2[J]. Obes Surg, 2014, 24(4):561-571.
[28] Favaro E, Granata R, Miceli I,et al. The ghrelin gene products andexendin-4 promote survival of human pancreatic islet endothelial cellsin hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt,extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A(PKA) signalling pathways[J]. Diabetologia, 2012, 55(4):1058-1070.
[29] Granata R, Settanni F, Biancone L, et al. Acylated and unacylatedghrelin promote proliferation and inhibit apoptosis of pancreaticbeta-cells and human islets: involvement of 3’,5’-cyclic adenosinemonophosphate/protein kinase A, extracellular signal-regulatedkinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling[J].Endocrinology, 2007, 148(2):512-529.
[30] Tuttle RL, Gill NS, Pugh W, et al. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha[J]. Nat Med, 2001, 7(10):1133-1137.
[31] Assmann A, Ueki K, Winnay JN, et al. Glucose effects on beta-cellgrowth and survival require activation of insulin receptors and insulinreceptor substrate 2[J]. Mol Cell Biol, 2009, 29(11):3219-3228.

相似文献/References:

[1]徐田磊 秦超 白日星.减肥手术的研究进展[J].中华肥胖与代谢病电子杂志,2016,2(01):7.[doi:10.3877//cma.j.issn.2095-9605.2016.01.002]
[2]褚薛慧 单晓东 邱晨 邓玲 孙喜太.多学科诊疗模式在代谢手术中的应用价值[J].中华肥胖与代谢病电子杂志,2016,2(01):12.[doi:10.3877//cma.j.issn.2095-9605.2016.01.003]
 Chu Xuehui,Shan Xiaodong,Qiu chen,et al.Application value of multidisciplinary treatment mode in metabolic surgery[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2016,2(02):12.[doi:10.3877//cma.j.issn.2095-9605.2016.01.003]
[3]陈宏 雒洪志 周小雕 余元龙 梁义 王存川.腹腔镜Roux-en-Y 胃旁路术在治疗肥胖型2 型糖尿病中的应用价值[J].中华肥胖与代谢病电子杂志,2016,2(01):26.[doi:10.3877//cma.j.issn.2095-9605.2016.01.006]
 Chen Hong,Luo Hongzhi,Zhou Xiaodiao,et al.Application value of laparoscopic Roux-en-Y gastric bypass in treating obese type 2 diabetes mellitus[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2016,2(02):26.[doi:10.3877//cma.j.issn.2095-9605.2016.01.006]
[4]李延兵.双管齐下:肥胖型2型糖尿病的内科治疗进展[J].中华肥胖与代谢病电子杂志,2015,1(03):113.[doi:10.3877//cma.j.issn.2095-9605.2015.03.001]
[5]张涛涛 张向文 梁怀祝 赵国华.腹腔镜Roux-en-Y胃旁路术治疗肥胖型2型糖尿病的三年随访研究[J].中华肥胖与代谢病电子杂志,2015,1(03):128.[doi:10.3877//cma.j.issn.2095-9605.2015.03.004]
 Zhang Taotao,Zhang Xiangwen,Liang Huaizhu,et al.Three-year follow-up study of laparoscopic Roux-en-Y gastric bypass for treating obese type 2 diabetes mellitus[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2015,1(02):128.[doi:10.3877//cma.j.issn.2095-9605.2015.03.004]
[6]何辉 李开春 李浩然 金实 董擂 程雷 李克军.腹腔镜Roux-en-Y胃旁路术在治疗2型糖尿病中的应用价值[J].中华肥胖与代谢病电子杂志,2015,1(03):137.[doi:10.3877//cma.j.issn.2095-9605.2015.03.006]
 He Hui,Li Kaichun,Li Haoran,et al.Clinical application value of laparoscopic Roux-en-Y gastric bypass for the treatment of type 2 diabetes mellitus[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2015,1(02):137.[doi:10.3877//cma.j.issn.2095-9605.2015.03.006]
[7]赵象文 关凯林 华伟 韩月峰 马育林 梁国仲.精准腹腔镜Roux-en-Y胃旁路术治疗肥胖型2型糖尿病的临床应用价值[J].中华肥胖与代谢病电子杂志,2015,1(03):142.[doi:10.3877//cma.j.issn.2095-9605.2015.03.007]
 Zhao Xiangwen,Guan Kailin,Hua Wei,et al.Clinical application value of precise laparoscopic Roux-en-Y gastric bypass for obese T2DM Zhao[J].Chinese Journal of Obesity and Metabolic Disease (Electronic Edition),2015,1(02):142.[doi:10.3877//cma.j.issn.2095-9605.2015.03.007]
[8]杨建军 王兵 顾岩.重视肥胖与代谢病外科的卫生经济学管理[J].中华肥胖与代谢病电子杂志,2015,1(03):150.[doi:10.3877//cma.j.issn.2095-9605.2015.03.009]
[9]秦晓光 白日星 宋茂民 闫文貌 汪鑫.胃收缩力调节器治疗2型糖尿病的研究进展[J].中华肥胖与代谢病电子杂志,2015,1(03):157.[doi:10.3877//cma.j.issn.2095-9605.2015.03.011]
[10]林伟达 骆衍新.减肥手术在结直肠肿瘤中的研究进展[J].中华肥胖与代谢病电子杂志,2015,1(03):164.[doi:10.3877//cma.j.issn.2095-9605.2015.03.013]

备注/Memo

备注/Memo:

通讯作者:张朝军,Email:1939618043@qq.com
更新日期/Last Update: 2016-05-30